Clinical Trial Update: A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome. [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind trial assessed fenofibrate, metformin, their combination, and placebo in patients with metabolic syndrome to evaluate efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• metformin (metformin)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Patients With Metabolic Syndrome | Phase 2 | Status: COMPLETED